Literature DB >> 9149061

Increased nitric oxide production and inducible nitric oxide synthase activity in colonic mucosa of patients with active ulcerative colitis and Crohn's disease.

H Kimura1, S Miura, T Shigematsu, N Ohkubo, Y Tsuzuki, I Kurose, H Higuchi, Y Akiba, R Hokari, M Hirokawa, H Serizawa, H Ishii.   

Abstract

It is postulated that an enhanced production of nitric oxide by inflamed intestine plays a role in the pathophysiology of active inflammatory bowel disease. In this study, systemic NOx concentrations and colonic nitric oxide synthase activity were determined in patients with ulcerative colitis or Crohn's disease. The relationship between these two parameters and disease activity, as well as differences in nitric oxide synthase activity between ulcerative colitis and Crohn's disease, were areas of specific focus. Patients with active ulcerative colitis and Crohn's disease had significantly elevated plasma NOx concentrations; a positive correlation was found between NOx values and inducible nitric oxide synthase activities in the active mucosa of these patients. In active ulcerative colitis, levels of inducible nitric oxide synthase were significantly elevated in both normal and inflamed mucosa, although inducible nitric oxide synthase activity was higher in the latter. These colonic inducible nitric oxide synthase activities correlated well with the results of endoscopic and histologic grading of inflammation. There was no increase in constitutive nitric oxide synthase activity in patients with active ulcerative colitis. However, constitutive nitric oxide synthase activity was significantly increased in the inflamed mucosa in patients with Crohn's disease. In Crohn's disease, elevated inducible nitric oxide synthase activity was found in both normal and inflamed mucosa, with no significant difference between the tissues. Such differences in nitric oxide production in the colonic mucosa possibly reflect the significant differences in the pathophysiology and characteristic clinical features between ulcerative colitis and Crohn's disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9149061     DOI: 10.1023/a:1018849405922

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  31 in total

1.  NO chi generation by cultured small intestinal epithelial cells.

Authors:  A U Dignass; D K Podolsky; D Rachmilewitz
Journal:  Dig Dis Sci       Date:  1995-09       Impact factor: 3.199

Review 2.  Cytokines in intestinal inflammation: pathophysiological and clinical considerations.

Authors:  R B Sartor
Journal:  Gastroenterology       Date:  1994-02       Impact factor: 22.682

3.  Enzyme linked immunosorbent assay (ELISA) and immunoprecipitation studies on anti-goblet cell antibody using a mucin producing cell line in patients with inflammatory bowel disease.

Authors:  T Hibi; M Ohara; K Kobayashi; W R Brown; K Toda; H Takaishi; Y Hosoda; A Hayashi; Y Iwao; M Watanabe
Journal:  Gut       Date:  1994-02       Impact factor: 23.059

Review 4.  Nitrite from inflammatory cells--a cancer risk factor in ulcerative colitis?

Authors:  W E Roediger; M J Lawson; B C Radcliffe
Journal:  Dis Colon Rectum       Date:  1990-12       Impact factor: 4.585

5.  Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide.

Authors:  J S Beckman; T W Beckman; J Chen; P A Marshall; B A Freeman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

6.  Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn's disease.

Authors:  D Rachmilewitz; J S Stamler; D Bachwich; F Karmeli; Z Ackerman; D K Podolsky
Journal:  Gut       Date:  1995-05       Impact factor: 23.059

7.  Nitric oxide synthase induction and intestinal epithelial cell viability in rats.

Authors:  B L Tepperman; J F Brown; B J Whittle
Journal:  Am J Physiol       Date:  1993-08

8.  Increased nitric oxide synthesis in ulcerative colitis.

Authors:  S J Middleton; M Shorthouse; J O Hunter
Journal:  Lancet       Date:  1993-02-20       Impact factor: 79.321

9.  Comparison of delayed release 5 aminosalicylic acid (mesalazine) and sulphasalazine in the treatment of mild to moderate ulcerative colitis relapse.

Authors:  S A Riley; V Mani; M J Goodman; M E Herd; S Dutt; L A Turnberg
Journal:  Gut       Date:  1988-05       Impact factor: 23.059

10.  Effects of nitric oxide synthase inhibition on the pathophysiology observed in a model of chronic granulomatous colitis.

Authors:  M B Grisham; R D Specian; T E Zimmerman
Journal:  J Pharmacol Exp Ther       Date:  1994-11       Impact factor: 4.030

View more
  41 in total

1.  Potentiation of cytokine induced iNOS expression in the human intestinal epithelial cell line, DLD-1, by cyclic AMP.

Authors:  M Cavicchi; B J Whittle
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

2.  Attenuation of host NO production by MAMPs potentiates development of the host in the squid-vibrio symbiosis.

Authors:  Melissa A Altura; Eric Stabb; William Goldman; Michael Apicella; Margaret J McFall-Ngai
Journal:  Cell Microbiol       Date:  2011-04       Impact factor: 3.715

Review 3.  Molecular Alterations of Colorectal Cancer with Inflammatory Bowel Disease.

Authors:  Masakazu Yashiro
Journal:  Dig Dis Sci       Date:  2015-04-04       Impact factor: 3.199

4.  The physiological expression of inducible nitric oxide synthase (iNOS) in the human colon.

Authors:  P J Roberts; G P Riley; K Morgan; R Miller; J O Hunter; S J Middleton
Journal:  J Clin Pathol       Date:  2001-04       Impact factor: 3.411

5.  Colorectal carcinoma development in inducible nitric oxide synthase-deficient mice with dextran sulfate sodium-induced ulcerative colitis.

Authors:  Darren N Seril; Jie Liao; Guang-Yu Yang
Journal:  Mol Carcinog       Date:  2007-05       Impact factor: 4.784

6.  Gene-centric association mapping of chromosome 3p implicates MST1 in IBD pathogenesis.

Authors:  P Goyette; C Lefebvre; A Ng; S R Brant; J H Cho; R H Duerr; M S Silverberg; K D Taylor; A Latiano; G Aumais; C Deslandres; G Jobin; V Annese; M J Daly; R J Xavier; J D Rioux
Journal:  Mucosal Immunol       Date:  2008-01-16       Impact factor: 7.313

Review 7.  Nitric oxide as a modulator of intestinal water and electrolyte transport.

Authors:  A A Izzo; N Mascolo; F Capasso
Journal:  Dig Dis Sci       Date:  1998-08       Impact factor: 3.199

8.  Crocetin reduces TNBS-induced experimental colitis in mice by downregulation of NFkB.

Authors:  Hamid A Kazi; Zhiyu Qian
Journal:  Saudi J Gastroenterol       Date:  2009 Jul-Sep       Impact factor: 2.485

9.  Nitric oxide as a potential biomarker in inflammatory bowel disease.

Authors:  Nesina Avdagić; Asija Zaćiragić; Nermina Babić; Mirsada Hukić; Mensura Seremet; Orhan Lepara; Emina Nakaš-Ićindić
Journal:  Bosn J Basic Med Sci       Date:  2013-02       Impact factor: 3.363

10.  Curcumin, the major component of food flavour turmeric, reduces mucosal injury in trinitrobenzene sulphonic acid-induced colitis.

Authors:  A Ukil; S Maity; S Karmakar; N Datta; J R Vedasiromoni; Pijush K Das
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.